Rachana Pradhan

Visit kff.org to read Rachana's bio.

rpradhan@kff.org
@rachanadpradhan

Millions of Dollars Flow From Pharma to Patient Advocacy Groups

KFF Health News Original

Pharma money is all over the place — in universities, companies doing continuing medical education for doctors and in prominent patient advocacy organizations that are household names across America. Public Citizen, a consumer advocacy nonprofit, reports today that between 2010 and 2022, the drug industry’s main lobbying group and member companies provided at least $6 […]

El daño colateral de la crisis de Medicaid: miles están perdiendo beneficios de alimentos

KFF Health News Original

Las familias de bajos ingresos que necesitan servicios como ayuda alimentaria y dinero en efectivo, se ven afectadas por la carrera burocrática para determinar si decenas de millones de personas aún califican para Medicaid.

Medicaid’s ‘Unwinding’ Can Be Especially Perilous for Disabled People

KFF Health News Original

Earlier this year, Beverly Likens thought she’d done everything she needed to do to keep her Medicaid. Then came an unwelcome surprise: Ahead of surgery to treat chronic bleeding, the hospital said her insurance was inactive, jeopardizing her procedure. Likens had just been diagnosed with severe anemia and given a blood transfusion at the emergency room. “I […]

The Painful Pandemic Lessons Mandy Cohen Carries to the CDC

KFF Health News Original

Mandy Cohen, the new director of the Centers for Disease Control and Prevention, earned praise for her leadership and communication as the face of North Carolina’s response to covid-19. People in the state’s most vulnerable communities tell a more complicated story.

Seeking Medicare Coverage for Weight Loss Drugs, Pharma Giant Courts Black Influencers

KFF Health News Original

Novo Nordisk, the dominant company in the multibillion-dollar market for weight loss drugs, focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease that needs treatment.

Idaho Dropped Thousands From Medicaid in the Pandemic’s First Years

KFF Health News Original

The removals, detailed in emails between state and federal health officials, hinged on disagreements over how states could disenroll people during the public health emergency. Consumer advocates fear the alleged violation signals the mess to come on April 1, when the pandemic-era Medicaid coverage mandate ends.

Why Medicaid Expansion Ballots May Hit a Dead End After a Fleeting Victory in South Dakota

KFF Health News Original

Since 2017, Medicaid expansion has been adopted in seven states where a question was placed directly on the ballot. But campaign leaders say that strategy may not work in Florida and Wyoming, where Republican opposition remains strong.

Empresas de capital riesgo invierten en el negocio de los ensayos clínicos de medicamentos. ¿Cuál es el riesgo para los pacientes?

KFF Health News Original

Para lanzar un nuevo fármaco al mercado, la Administración de Alimentos y Medicamentos (FDA) exige a las farmacéuticas estudios exhaustivos para demostrar su seguridad y eficacia. Conseguir que un medicamento salga al mercado unos meses antes, y con menos gastos de lo habitual, puede traducirse en beneficios millonarios para el fabricante.